Publication | Closed Access
Initial clinical experience with the GORE<sup>®</sup> CARDIOFORM ASD occluder for transcatheter atrial septal defect closure
35
Citations
21
References
2017
Year
In this first-in-man multicenter study, the GCO was safe and effective for ASD closure, with no major adverse events or residual shunt at follow-up. © 2017 Wiley Periodicals, Inc.
| Year | Citations | |
|---|---|---|
Page 1
Page 1